County
Clark County EMS (Washington)
An undated version is under review. The figures below are from the current listed document.
Drugs and doses45
A–C Acetaminophen, Activated Charcoal, Adenosine, Albuterol, Albuterol-Ipratropium, Amiodarone, Aspirin, Atropine, Buprenorphine, Calcium Chloride, Calcium Gluconate11
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 15 mg/kg | PR | not captured | standing | page 8 |
| Mild to moderate pain | adult | 1000 mg | PO/ODT | not captured | standing | page 8 |
| Mild to moderate pain | adult | 1000 mg | IV | not captured | standing | page 8 |
| Mild to moderate pain | peds | 15 mg/kg | PO/ODT | not captured | standing | page 8 |
| Mild to moderate pain | peds | 15 mg/kg | IV/PO/PR | not captured | standing | page 53 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 50 g | PO | not captured | standing | page 8 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 6 mg | IV | not captured | standing | page 8 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV | not captured | standing | page 8 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 5 mg | NEB | not captured | standing | page 8 |
| Asthma / bronchospasm | peds | 2.5–5 mg | NEB | not captured | standing | page 8 |
| Hyperkalemia | adult | 5 mg | NEB | not captured | standing | page 8 |
| Hyperkalemia | peds | 2.5–5 mg | NEB | not captured | standing | page 8 |
Albuterol-Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 3 mL | NEB | not captured | standing | page 10 |
| Asthma / bronchospasm | peds | 1.5 mL | NEB | not captured | standing | page 10 |
| Hyperkalemia | adult | 3 mL | NEB | not captured | standing | page 10 |
| Hyperkalemia | peds | 1.5 mL | NEB | not captured | standing | page 10 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV | not captured | standing | page 8 |
| Other | peds | 5 mg/kg | IV | not captured | standing | page 8 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 8 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 8 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 8 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 9 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 9 |
| Organophosphate poisoning | adult | 2 mg | IV/IM | not captured | standing | page 9 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV/IM | not captured | standing | page 9 |
Buprenorphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 16 mg | SL | not captured | standing | page 137 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 g | IV/IO | not captured | standing | page 9 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 10 mg/kg | IV/IO | not captured | standing | page 9 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 9 |
| Hyperkalemia | peds | 10 mg/kg | IV/IO | not captured | standing | page 9 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 3 g | IV/IO | not captured | standing | page 9 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 60 mg/kg | IV/IO | not captured | standing | page 9 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 9 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | page 9 |
| Other | adult | 3 g | IV/IO | not captured | standing | page 9 |
| Other | adult | 3 g | IV/IO | not captured | standing | page 9 |
| Other | peds | 1 mL | NEB | not captured | standing | page 9 |
D–F Dexamethasone, Dextrose, Diltiazem, Diphenhydramine, Droperidol, Epinephrine, Etomidate, Fentanyl8
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 10 mg | IV/IM/PO | not captured | standing | page 9 |
| Anaphylaxis | peds | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 9 |
| Asthma / bronchospasm | adult | 10 mg | IV/IM/PO | not captured | standing | page 9 |
| Asthma / bronchospasm | peds | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 9 |
| Croup | adult | 10 mg | IV/IM/PO | not captured | standing | page 9 |
| Croup | peds | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 9 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 10 g | IV/IO | not captured | standing | page 9 |
| Hypoglycemia | peds | 2.5 mL/kg | IV/IO | not captured | standing | page 9 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 10 |
| SVT | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 10 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1 mg/kg | IV/IM/PO | not captured | standing | page 10 |
| Anaphylaxis | peds | 1 mg/kg | IV/IM/PO | not captured | standing | page 10 |
| Dystonic reaction | adult | 1 mg/kg | IV/IM | not captured | standing | page 56 |
| Dystonic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 56 |
| Other | adult | 1 mg/kg | IV/IM/PO | not captured | standing | page 10 |
| Other | peds | 1 mg/kg | IV/IM/PO | not captured | standing | page 10 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV/IM | not captured | standing | page 10 |
| Agitation | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 10 |
| Nausea / vomiting | adult | 1.25 mg | IV/IO/IM | not captured | standing | page 10 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 10 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 10 |
| Bradycardia | adult | 2–40 mcg | IV/IO | not captured | standing | page 10 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 10 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 10 |
| Croup | peds | 0.5 mL/kg | NEB | not captured | standing | page 10 |
| Hypotension / shock | adult | 10–20 mcg | IV/IO | not captured | standing | page 11 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 0.15 mg/kg | IV/IO | not captured | standing | page 11 |
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 11 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 11 |
| ACS / chest pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 11 |
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 11 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 11 |
| Post-intubation sedation | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 11 |
G–L Glucagon, Haloperidol, Ipratropium, Ketamine, Ketorolac, Labetalol, Levalbuterol, Lidocaine8
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 11 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 10 mg | IM | not captured | standing | page 11 |
| Agitation | adult | 2.5–5 mg | IV/IM | not captured | standing | page 11 |
| Agitation | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 11 |
| Agitation | peds | 0.1 mg/kg | IM | not captured | standing | page 11 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 11 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | page 11 |
| Mild to moderate pain | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 11 |
| Mild to moderate pain | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 11 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | page 53 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 12 |
| Mild to moderate pain | peds | 0.5 mg/kg | IM | not captured | standing | page 12 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV | not captured | standing | page 53 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20 mg | IV | not captured | standing | page 12 |
Levalbuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 12 |
| Asthma / bronchospasm | peds | 1.25 mg | NEB | not captured | standing | page 12 |
| Hyperkalemia | adult | 2.5 mg | NEB | not captured | standing | page 12 |
| Hyperkalemia | peds | 1.25 mg | NEB | not captured | standing | page 12 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 12 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 12 |
| Mild to moderate pain | adult | 40 mg | IO | not captured | standing | page 12 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | page 12 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Naloxone, Nitroglycerin, Norepinephrine, Olanzapine, Ondansetron, Oral Glucose, Oxymetazoline10
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | page 12 |
| Respiratory distress | adult | 2 g | IV | not captured | standing | page 12 |
| Respiratory distress | peds | 50 mg/kg | IV | not captured | standing | page 12 |
| Tricyclic overdose | adult | 2 g | IV | not captured | standing | page 12 |
| Tricyclic overdose | peds | 50 mg/kg | IV | not captured | standing | page 12 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | page 12 |
| VF / pulseless VT | peds | 50 mg/kg | IV/IO | not captured | standing | page 12 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV | not captured | standing | page 12 |
| Anaphylaxis | peds | 2 mg/kg | IV | not captured | standing | page 12 |
| Asthma / bronchospasm | adult | 125 mg | IV | not captured | standing | page 12 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV | not captured | standing | page 12 |
| Other | adult | 125 mg | IV | not captured | standing | page 12 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV/IM | not captured | standing | page 13 |
| Agitation | peds | 0.2 mg/kg | IV/IM | not captured | standing | page 13 |
| Other | adult | 2.25 mg | IV/IM | not captured | standing | page 13 |
| Other | adult | 2.5 mg | IV | not captured | standing | page 13 |
| Other | peds | 0.2 mg/kg | IV/IM | not captured | standing | page 13 |
| Other | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 13 |
| Post-intubation sedation | adult | 5 mg | IV/IO | not captured | standing | page 13 |
| Procedural sedation | adult | 2.5–5 mg | IV/IM | not captured | standing | page 13 |
| Procedural sedation | adult | 2.5–5 mg | IV/IO/IM | not captured | standing | page 38 |
| Procedural sedation | peds | 0.2 mg/kg | IV/IM | not captured | standing | page 13 |
| Procedural sedation | peds | 0.2 mg/kg | IV/IO/IM | not captured | standing | page 38 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 13 |
| Seizure | adult | 2.5–5 mg | IV/IM | not captured | standing | page 13 |
| Seizure | adult | 5 mg | IV/IO | not captured | standing | page 13 |
| Seizure | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 13 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 13 |
| Seizure | peds | 0.2 mg/kg | IN | not captured | standing | page 13 |
| Seizure | peds | 0.2 mg/kg | IV/IM | not captured | standing | page 13 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.5–2 mg | IV | not captured | standing | page 14 |
| Opioid overdose | adult | 2 mg | IM/IN | not captured | standing | page 14 |
| Opioid overdose | peds | 0.1 mg/kg | IM/IN | not captured | standing | page 14 |
| Opioid overdose | peds | 0.1 mg/kg | IV | not captured | standing | page 14 |
| Other | adult | 0.5–2 mg | IV | not captured | standing | page 58 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 59 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 14 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 14 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 4 mcg | IV/IO | not captured | standing | page 14 |
| Hypotension / shock | peds | 0.1 mcg/kg | IV/IO | not captured | standing | page 14 |
Olanzapine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 10 mg | ODT | not captured | standing | page 14 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 8 mg | IV/IM/PO | not captured | standing | page 14 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM/PO | not captured | standing | page 14 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | page 20 |
| Hypoglycemia | peds | 15 g | PO | not captured | standing | page 20 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | page 14 |
P–R Racemic Epinephrine, Rocuronium2
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Croup | peds | 0.05 mL/kg | NEB | not captured | standing | page 14 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg/kg | IV | not captured | standing | page 14 |
| RSI induction | adult | 1.5 mg/kg | IV | not captured | standing | page 14 |
S–Z Sodium Bicarbonate, Sodium Thiosulfate, Succinylcholine, Tranexamic Acid, Vecuronium, Verapamil6
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Head injury / TBI | adult | 1 mEq/kg | IV | not captured | standing | page 14 |
| Tricyclic overdose | adult | 1 mEq/kg | IV | not captured | standing | page 14 |
| Tricyclic overdose | peds | 1 mEq/kg | IV | not captured | standing | page 14 |
Sodium Thiosulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 50 mL | IV/IO | not captured | standing | page 14 |
| Cyanide poisoning | peds | 1.6 mL/kg | IV/IO | not captured | standing | page 14 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.5 mg/kg | IV | not captured | standing | page 15 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 1 g | IV | not captured | standing | page 15 |
| Other | adult | 0.5 g | IN | not captured | standing | page 15 |
| Trauma / hemorrhage | adult | 2 g | IV | not captured | standing | page 15 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg/kg | IV | not captured | standing | page 15 |
Verapamil
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 5 mg | IV | not captured | standing | page 15 |
Cite this
Clark County EMS (Washington), United States EMS Protocol Census. 152 dose entries, effective 2026-03-01.
https://protoquiz.com/census/agencies/clark-county-ems-washington/
The census is free and not for sale. Only public agencies are named.